Skip to main content

Table 2 Patients’ satisfaction scores at baseline, 3-months, 6-months, 9-months and 12-months follow-ups

From: A non-clinical randomised controlled trial to assess the impact of pharmaceutical care intervention on satisfaction level of newly diagnosed diabetes mellitus patients in a tertiary care teaching hospital in Nepal

Groups Control group Test 1 group (PC group) Test 2 group (PC + Diabetic kit group)
Follow-ups Median score (IQR) Median score (IQR) Median score (IQR)
Baseline 44 [(42)-(46)] 45 [(42)-(46)] 43 [(41)-(46)]
3-months (1st F/U) 50 [(48)-(51)] 66 [(64)-(69)] 68 [(66)-(70)]
6-months (2nd F/U) 49 [(48)-(50)] 67 [(65)-(70)] 69 [(66)-(71)]
9-months (3rd F/U) 49 [(48)-(50)] 68 [(66)-(70)] 69 [(68)-(73)]
12-months (4th F/U) 47.74 [(47)-(48.25)] 68 [(66)-(70)] 73 [(70)-(75)]